| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.8 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |